About
Doctronic, founded in 2024 in New York, USA, provides AI-powered telehealth services that combine personalized virtual care with licensed clinician consultations.
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Funding history
- 2026-03Series B$40M
Investors · Seven Stars, Union Square Ventures, Mantis VC, Tusk Ventures, Lightspeed, Abstract VenturesSource · SVTR Weekly #150 ↗
- 2025-09Series A$20M
Investors · Abstract Ventures, Lightspeed, Mantis VC, Seven Stars, Union Square Ventures, Tusk VenturesSource · SVTR Weekly #123
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- Doctronic
AI-driven telehealth services
Series B · $80M · 2026-03
$80M
United States
BusinessLatest roundTotal raisedDate- Plenful
AI-driven workflow automation platform that simplifies administrative tasks for pharmacies and healthcare providers
Series B · $59M · 2025-05
$59M - Candid Health
Provides AI-driven revenue cycle management (RCM) for healthcare providers, automating claims, billing, collections and denials
Series D+ · $120M · 2026-07
$120M - Akido Labs
AI tools for healthcare providers that generate clinical questions, record patient answers and streamline care workflows
Series B · $60M · 2025-05
$60M
China
BusinessLatest roundTotal raisedDateEurope
BusinessLatest roundTotal raisedDate- Tandem Health
AI clinical assistant for European healthcare providers: pre-visit summaries, real-time consultation transcription, and automatic post-visit generation of medical records and diagnostic codes
Series B · $160M · 2026-09
$160M - Flok Health
AI-run physical therapy that diagnoses, triages, treats and discharges musculoskeletal patients for health systems via mobile consultations
Series A · $13M · 2026-06
$13M - Vocca
Specialty AI voice front desk for medical practices that answers patient calls and completes scheduling and administrative tasks directly in scheduling/EHR systems
Series A · $25M · 2026-10
$25M
Other / unspecified
BusinessLatest roundTotal raisedDate- Even Healthcare
Health subscription membership for individuals and businesses (unlimited consultations, free testing), with a company-operated network of hospitals and clinics and accompanying health insurance.
Series B · $120M · 2026-10 · Valuation $300M
$120MValuation $300M - Craif
Urine microRNA plus AI early cancer detection service (miSignal) and software medical device development for pancreatic cancer diagnosis
Series D+ · $88M · 2026-08
$88M - TytoCare
Handheld medical devices combined with AI software for doctors' remote physical exams
Undisclosed · 2026-07
—
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
General Catalyst
39 Life Sciences deals in the last 24 months · 21 at a nearby stage · 35 in NYC Metro
Request intro →Y Combinator
38 Life Sciences deals in the last 24 months · 19 at a nearby stage · 31 in NYC Metro
Request intro →Andreessen Horowitz
24 Life Sciences deals in the last 24 months · 14 at a nearby stage · 22 in NYC Metro
Request intro →Khosla Ventures
21 Life Sciences deals in the last 24 months · 11 at a nearby stage · 20 in NYC Metro
Request intro →Thrive Capital
18 Life Sciences deals in the last 24 months · 12 at a nearby stage · 15 in NYC Metro
Request intro →8VC
14 Life Sciences deals in the last 24 months · 9 at a nearby stage · 14 in NYC Metro
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.